PRIMERA Trial
Cross-source consensus on PRIMERA Trial from 1 sources and 4 claims.
1 sources · 4 claims
Comparisons
Other
Other
Other
Highlighted claims
- PRIMERA is a multicentre, open-label randomised controlled trial conducted in the Netherlands. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- The trial compares routine care with a structured personalised treatment strategy for rheumatoid arthritis. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- Recruitment, follow-up, and data cleaning cover the period from December 2019 to December 2025. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- The trial aims to enrol 300 newly diagnosed, DMARD-naive rheumatoid arthritis patients. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach